ESC 365 - Unravelling the diversity of cholinesterases in the murine heart as an essential prerequisite for the use of cholinesterase inhibitors in the treatment of heart failure

HFA Premium Access

Unravelling the diversity of cholinesterases in the murine heart as an essential prerequisite for the use of cholinesterase inhibitors in the treatment of heart failure

Session: Basic science

Topic: Cardiac Biology and Physiology

Speaker: Associate Professor A. Hrabovska (Bratislava, SK)

Event: Heart Failure 2024

Congress Presentation

About the speaker

Associate Professor Anna Hrabovska

Faculty Of Pharmacy, Comenius University, Bratislava (Slovakia)

0 follower

4 more presentations in this session

CDK4/6 inhibitor ribociclib induces cardiotoxicity in dynamic engineered heart tissues, mitigated by E2F1 overexpression

Speaker: Mr I. Dias (Groningen, NL)

Cellular phenotyping of structural and functional changes in atrial myopathy

Speaker: Doctor J. Huettemeister (Berlin, DE)

Non-dilated left ventricular cardiomyopathy with arrhythmias is caused by the nonsense founder variant DSP:c.3793G>T in Slovenian patients

Speaker: Ms N. Vodnjov (Ljubljana, SI)

Effect of empagliflozin with or without sacubitril/valsartan on the lipoprotein, glycoprotein and lipid profile in a porcine model of myocardial infarction

Speaker: Miss D. Martinez-Falguera (Badalona, ES)

Access the full session

Basic science

Speakers: Associate Professor A. Hrabovska, Mr I. Dias, Doctor J. Huettemeister, Ms N. Vodnjov, Miss D. Martinez-Falguera

About the event

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources